Citation Impact
Citing Papers
Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients
1996
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
2013
Management of hepatitis B
2007
Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
2016
Cochrane Database of Systematic Reviews
2003 Standout
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
2000
Cancer Statistics, 2021
2021 Standout
Endovascular arterial intervention: Expression of concern
1995
Bypass surgery for chronic lower limb ischaemia
2000
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
1996
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy
1996
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts
2011
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
A view on drug resistance in cancer
2019 StandoutNature
Peripheral vascular brachytherapy
2002
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Efficacy of Pneumococcal Vaccination in Adults
1994
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
2008
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function†
2009
High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection
1995
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
1991
Predictors of Long-term Patency after Femoropopliteal Angioplasty: Results from the STAR Registry
2001
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis
2016
Hepatitis B Virus Infection
2008
Patency Results of Percutaneous and Surgical Revascularization for Femoropopliteal Arterial Disease
1994
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
2009
Bacterial Infection in Chronic Obstructive Pulmonary Disease
1992
Antigen-specific antibody responses in lupus patients following immunization
1998
Hepatitis B viruses: Reverse transcription a different way
2008
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
2008
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
2012
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
1997
The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
1999
Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?
2009
Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
2011
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #
2009
Hepatitis B virus infection
2009 Standout
Rescue therapy for lamivudine‐resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add‐on lamivudine combination therapy
2010
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
1991
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
1998
A Genomic and Functional Inventory of Deubiquitinating Enzymes
2005 Standout
Entecavir resistance is rare in nucleoside naïve patients with hepatitis B
2006
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn Atlanta
1995
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA)
1991
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B
2012
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti‐viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
2008
Antigenic Variation of Penicillin-Binding Proteins from Penicillin-Resistant Clinical Strains of Streptococcus pneumoniae
1991
Percutaneous angioplasty and stenting of the superficial femoral artery
2005
Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia
2001
Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
2008
Angioplasty or Bypass for Superficial Femoral Artery Disease? A Randomised Controlled Trial
2004
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
2006 Standout
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
2009
Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level withRisk of Clinical Progression in Patients with Advanced Infection
1996
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
1997
Primary Patency of Femoropopliteal Arteries Treated with Nitinol versus Stainless Steel Self-expanding Stents: Propensity Score–adjusted Analysis
2004
Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists
2004
Systemic Lupus Erythematosus
2011 Standout
Chronic hepatitis B
2007 Standout
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
2007
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis
2013
Antiretroviral Drug Resistance: Mechanisms, Pathogenesis, Clinical Significance
1996
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
2011
Chronic hepatitis B: Update 2009 #
2009 Standout
Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection
2001
Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults
2002
A RING Finger Ubiquitin Ligase Is Protected from Autocatalyzed Ubiquitination and Degradation by Binding to Ubiquitin-specific Protease USP7
2004
Infections in Patients with Diabetes Mellitus
1999 Standout
Balloon angioplasty of popliteal and crural arteries in elderly with critical chronic limb ischemia
2004
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
2008
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside‐naïve HBeAg‐positive patients with chronic hepatitis B
2009
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
2003
Considerations in choice of a clinical endpoint for AIDS clinical trials
1994
Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
2013
HIV as the cause of AIDS
1996 StandoutNobel
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B
2007
Thromboendarterectomy for obstructive disease of the common iliac artery
1996
Endoluminal Stent–Grafts for Infrarenal Abdominal Aortic Aneurysms
1997 Standout
Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation
2016
Should patients positive for HIV infection receive pneumococcal vaccine?
1995
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
2007
Immunoglobulin G and Its Function in the Human Respiratory Tract
1988
Antimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
1991
Transcatheter Interventions for the Treatment of Peripheral Atherosclerotic Lesions: Part I
2001
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
2006
Inefficacy of pneumococcal vaccine in a high-risk population
1987
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
2008
Primary Patency of Long-Segment Self-Expanding Nitinol Stents in the Femoropopliteal Arteries
2005
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
2007
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
2006
Bypass surgery for chronic lower limb ischaemia
2008
World-wide development of antibiotic resistance in pneumococci
1987
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials
2001
Bypass or Angioplasty for Severe Limb Ischaemia? A Delphi Consensus Study
2002
Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older
1999
SARS-CoV-2 vaccines in development
2020 StandoutNature
Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis
2002
BACTERIAL PNEUMONIA ASSOCIATED WITH HIV-1 INFECTION
1996
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
2008
HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
2008
Sustained Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B after Adefovir Dipivoxil Treatment: Analysis of Precore and Basal Core Promoter Mutants
2008
Entecavir therapy for lamivudine‐refractory chronic hepatitis B
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial
2005 Standout
Pneumococcal vaccination. Controversies and opportunities.
1990
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
AASLD guidelines for treatment of chronic hepatitis B
2015
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Revascularization for Femoropopliteal Disease
1995
Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
1997
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Entecavir Exhibits Inhibitory Activity against Human Immunodeficiency Virus under Conditions of Reduced Viral Challenge
2008
Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection—Impact of Antiviral Treatments
2010
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
2010
A Pre-Immediate-Early Role for Tegument ICP0 in the Proteasome-Dependent Entry of Herpes Simplex Virus
2011
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
1996
Hospital-Based Pneumococcal Immunization
1990
Cost and outcome implications of the organisation of vascular services.
2000
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Angioplasty and Elective Stenting of De Novo versus Recurrent Femoropopliteal Lesions: 1-Year Follow-up
2003
The Pneumococcal Vaccine After 15 Years of Use
1994
Suboptimal Response to Adefovir Dipivoxil Therapy for Chronic Hepatitis B in Nucleoside-Naive Patients is not due to Pre-Existing Drug-Resistant Mutants
2008
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
1988
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
2010
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Prevention of pneumococcal disease.
1998
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Pathogenesis of human immunodeficiency virus infection
1993
Clinical effectiveness of pneumococcal vaccine. Meta-analysis.
1999
Inhibition of Hepatitis B Virus Polymerase by Entecavir
2007
Adding adefovir vs. switching to entecavir for lamivudine‐resistant chronic hepatitis B (ACE study): a 2‐year follow‐up randomized controlled trial
2012
The Crisis in Antibiotic Resistance
1992 StandoutScience
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
2017
Preventing Pneumococcal Bacteremia in Patients at Risk
1995
Are Infra-Inguinal Angioplasty and Surgery Comparable?
2001
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
MR Angiography in the Evaluation of Atherosclerotic Peripheral Vascular Disease
2000
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
2012
Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
1996
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
Pneumococcal Vaccination
1990
Diagnosis of Bacterial Infections of the Lung
1987
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis
2015
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
2017
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Pneumococcal Polysaccharide Vaccine Efficacy
1993
Pneumococcal Vaccine After 15 Years of Use
1994
Vaccination anti-pneumococcique : place et indications dans la prévention des infections communautaires des voies respiratoires inférieures
2001
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
Works of Anne Cross being referenced
Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
2006
Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B
2008
Surgery or Balloon Angioplasty for Peripheral Vascular Disease: A Randomized Clinical Trial
1993
A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection
1992
A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
2006
Proximal Percutaneous Balloon Angioplasty and Distal Bypass for Multilevel Arterial Occlusion
1990
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
2006
[49] ENTECAVIR (ETV) RESULTS IN HIGHER HBV-DNA REDUCTION VS ADEFOVIR (ADV) IN CHRONICALLY INFECTED HBeAg(+) ANTIVIRAL-NAIVE ADULTS: 48 WK RESULTS (E.A.R.L. STUDY)
2007
A Truncated Form of Herpes Simplex Virus Type 1 Immediate-Early Protein Vmw110 Is Expressed in a Cell Type Dependent Manner
1993
[781] FOUR YEAR ASSESSMENT OF ETV RESISTANCE IN NUCLEOSIDE-NAIVE AND LAMIVUDINE REFRACTORY PATIENTS
2007
Efficacy of Pneumococcal Vaccine in High-Risk Patients
1986
Antibiotic-Resistant Isolates of Streptococcus pneumoniae from Clinical Specimens: A Cluster of Serotype 19A Organisms in Brooklyn, New York
1986
P.090 Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
2006
Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis
1989
Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis
1989